Euclidean Capital LLC Long-Term Concentrated

CIK: 0001825034 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $472,377 (100.0% shares, 0.0% debt)

Holdings (10)

PMVP PMV PHARMACEUTICALS INC 54.4%
Value ($000) $257,076 Shares 4,179,416 Est. Cost $39.23 Unrealized 0.0%
— NGM BIOPHARMACEUTICALS INC 13.4%
Value ($000) $63,133 Shares 2,083,602 Est. Cost $30.30 Unrealized —
ORIC ORIC PHARMACEUTICALS INC 10.0%
Value ($000) $47,405 Shares 1,400,435 Est. Cost $28.69 Unrealized 0.0%
DNLI DENALI THERAPEUTICS INC 5.7%
Value ($000) $27,117 Shares 323,749 Est. Cost $60.45 Unrealized 0.0%
FHTX FOGHORN THERAPEUTICS INC 5.4%
Value ($000) $25,566 Shares 1,261,261 Est. Cost $19.16 Unrealized 0.0%
— CONSTELLATION PHARMCETICLS I 3.4%
Value ($000) $15,965 Shares 554,325 Est. Cost $28.80 Unrealized —
ALEC ALECTOR INC 3.1%
Value ($000) $14,841 Shares 980,894 Est. Cost $12.43 Unrealized 0.0%
— RAPT THERAPEUTICS INC 3.1%
Value ($000) $14,532 Shares 735,801 Est. Cost $19.75 Unrealized —
RVMD REVOLUTION MEDICINES INC 0.8%
Value ($000) $3,699 Shares 93,436 Est. Cost $39.54 Unrealized 0.0%
FFBC FIRST FINL BANCORP OH 0.6%
Value ($000) $3,043 Shares 173,576 Est. Cost $12.77 Unrealized 0.0%